USPTO 2015–2025 USPTO PatentsView US Corporation

Therabody, Inc.

USPTO PatentsView assignee record - 141 granted patents across 24 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI).

141
Total patents granted
24
CPC technology areas
6.0
Avg claims per patent
-
5-year filing velocity

The verdict

Therabody holds 141 US patents across 24 technology areas, rank #2,749 of 50,000 tracked assignees.

#2,749
of 50,000 US assignees by volume
Top 5%
by Innovation Score (58.0/100)
6.0
avg claims per patent

Portfolio overview

Therabody, Inc. has been granted 141 US utility patents between 2021 and 2025, placing Therabody, Inc. at rank #2,749 across all assignees tracked by PlainPatent. This portfolio spans 24 distinct Cooperative Patent Classification (CPC) subclasses, averaging 6.0 claims per patent with primary concentration in A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI). As a US Corporation, Therabody, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Therabody sits between Marathon Petroleum Company Lp (141 patents, rank #2,745) and Assa Abloy Entrance Systems AB (140 patents, rank #2,753) - the closest US assignees by grant volume. The composite Innovation Score of 58.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 141 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Therabody, Inc.'s 6.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 24 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Therabody, Inc. against peers pursuing similar technology classes.

Who files at Therabody's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Therabody holds 141 patents at rank #2,749, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Therabody

By rank, the assignees closest to #2,749 in granted patent volume.

Leaders in A61H (Physical Therapy Apparatus)

Other assignees with the most granted patents in Therabody's primary technology class.

Therabody's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

58 Top 5% higher than 95% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

-200204060 20212022202320242025 21
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Therabody, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 1 0.7%
2022 23 16.3%
2023 53 37.6%
2024 43 30.5%
2025 21 14.9%

Which technologies does Therabody, Inc. patent most?

Top 15 of 24 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Simple

Where it ranks

Overall rank by patents

#2,749

Across all tracked assignees

Innovation Score

58.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Therabody, Inc. hold?
Therabody, Inc. holds 141 US granted patents filed between 2021 and 2025, spanning 24 technology areas.
What is Therabody, Inc.'s Innovation Score?
Therabody, Inc. has an Innovation Score of 58.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Therabody, Inc. focus on?
Therabody, Inc.'s top technology area is A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY) with 34 patents. The company has filed patents in 24 CPC subclasses total.
Is Therabody, Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Therabody, Inc..
What does claim depth mean for Therabody, Inc.'s patents?
Therabody, Inc.'s patents average 6.0 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Therabody, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Therabody's 141 grants land it in the top 5% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Therabody ranks #2,749 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61H - see who else leads that technology area. A61H leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.